Holen Sie sich die Stockscreener-App
27.88
2.42%
-0.69
Handel nachbörslich:
27.50
-0.38
-1.36%
Finanzdaten der Vera Therapeutics Inc-Aktie (VERA)
Gewinn- und Verlustrechnung
Vierteljährlich
*Alle Zahlen in Millionen
| Enddatum des Zeitraums | 2026-06-30 | 2026-03-31 | 2025-12-31 | 2025-09-30 | 2025-06-30 |
| Periodenlänge | 3 Monate | 3 Monate | 3 Monate | 3 Monate | 3 Monate |
| Operating Expenses |
10.10%
112.49
|
125.13 | 94.21 | 83.93 | 80.14 |
| Operating Income/Loss |
10.10%
-112.49
|
-125.13 | -94.21 | -83.93 | -80.14 |
| Nonoperating Income/Loss |
26.41%
3.017
|
4.10 | 3.11 | 3.639 | 3.61 |
| Net Income/Loss |
9.55%
-109.47
|
-121.03 | -91.10 | -80.29 | -76.53 |
| Basic Average Shares |
0.51%
71.84
|
71.48 | 0.4639 | 63.85 | 63.79 |
| Diluted Average Shares |
0.51%
71.84
|
71.48 | 0.4639 | 63.85 | 63.79 |
| Basic Earnings Per Share |
10.06%
-1.52
|
-1.69 | -1.39 | -1.26 | -1.20 |
| Diluted Earnings Per Share |
10.06%
-1.52
|
-1.69 | -1.39 | -1.26 | -1.20 |
11.99%
In Yahoo öffnen
|
In Google öffnen
|
In Finviz öffnen
|
In MarketWatch öffnen
|
Öffnen Sie in EDGAR
|
Offen in Reuters
Kapitalisierung:
|
Volumen (24h):